Coronary heart disease (CHD) is the leading cause of death worldwide. Coronary artery
bypass graft (CABG) surgery remains the procedure of choice for coronary artery …

Cardiac surgery patients are now more risky in terms of age, comorbidities, and the need for
complex procedures. It brings about reperfusion injury, which leads to dysfunction and/or …

Coronary artery bypass graft (CABG) surgery remains the procedure of choice for coronary
artery revascularization in patients with multi-vessel coronary artery disease (CAD). For …

Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. For
a large number of patients with CHD, coronary artery bypass graft (CABG) surgery remains …

The aim of pharmacological conditioning is to protect the heart against myocardial ischemia-
reperfusion (I/R) injury and its consequences. There is extensive literature that reports a …

Cardioprotection encompasses a variety of strategies protecting the heart against
myocardial injury that occurs during and after inadequate blood supply to the heart during …

Ischemia–reperfusion is a major determinant of myocardial impairment in patients
undergoing cardiac surgery. The main goal of research in cardioprotection is to develop …

Acute myocardial ischemic insult remains the most prevalent cause of postoperative
mortality and morbidity despite major advances in cardiovascular medicine. Preoperative …

Myocardial protection has become an essential adjunctive measure in cardiac surgery for a
couple of decades, because since the 1950s, the methods of cardioprotection (cardioplegic …

Coronary artery disease (CAD) is a major cause of morbidity and mortality worldwide.
Coronary artery bypass graft (CABG) surgery is the revascularisation strategy of choice in …